chr22-19978040-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001670.3(ARVCF):​c.1616G>A​(p.Arg539Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0096 in 1,611,380 control chromosomes in the GnomAD database, including 88 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0059 ( 6 hom., cov: 33)
Exomes 𝑓: 0.010 ( 82 hom. )

Consequence

ARVCF
NM_001670.3 missense

Scores

1
4
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.54

Publications

15 publications found
Variant links:
Genes affected
ARVCF (HGNC:728): (ARVCF delta catenin family member) Armadillo Repeat gene deleted in Velo-Cardio-Facial syndrome (ARVCF) is a member of the catenin family. This family plays an important role in the formation of adherens junction complexes, which are thought to facilitate communication between the inside and outside environments of a cell. The ARVCF gene was isolated in the search for the genetic defect responsible for the autosomal dominant Velo-Cardio-Facial syndrome (VCFS), a relatively common human disorder with phenotypic features including cleft palate, conotruncal heart defects and facial dysmorphology. The ARVCF gene encodes a protein containing two motifs, a coiled coil domain in the N-terminus and a 10 armadillo repeat sequence in the midregion. Since these sequences can facilitate protein-protein interactions ARVCF is thought to function in a protein complex. In addition, ARVCF contains a predicted nuclear-targeting sequence suggesting that it may have a function as a nuclear protein. [provided by RefSeq, Jun 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011663407).
BP6
Variant 22-19978040-C-T is Benign according to our data. Variant chr22-19978040-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 445517.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARVCFNM_001670.3 linkc.1616G>A p.Arg539Gln missense_variant Exon 8 of 20 ENST00000263207.8 NP_001661.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARVCFENST00000263207.8 linkc.1616G>A p.Arg539Gln missense_variant Exon 8 of 20 1 NM_001670.3 ENSP00000263207.3

Frequencies

GnomAD3 genomes
AF:
0.00593
AC:
903
AN:
152210
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00186
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00249
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00558
Gnomad FIN
AF:
0.00292
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0106
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00630
AC:
1563
AN:
248266
AF XY:
0.00657
show subpopulations
Gnomad AFR exome
AF:
0.00143
Gnomad AMR exome
AF:
0.00166
Gnomad ASJ exome
AF:
0.000101
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00314
Gnomad NFE exome
AF:
0.0109
Gnomad OTH exome
AF:
0.00579
GnomAD4 exome
AF:
0.00998
AC:
14564
AN:
1459052
Hom.:
82
Cov.:
31
AF XY:
0.00981
AC XY:
7117
AN XY:
725712
show subpopulations
African (AFR)
AF:
0.00149
AC:
50
AN:
33450
American (AMR)
AF:
0.00153
AC:
68
AN:
44586
Ashkenazi Jewish (ASJ)
AF:
0.000192
AC:
5
AN:
26086
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39664
South Asian (SAS)
AF:
0.00620
AC:
534
AN:
86162
European-Finnish (FIN)
AF:
0.00395
AC:
205
AN:
51878
Middle Eastern (MID)
AF:
0.00278
AC:
16
AN:
5758
European-Non Finnish (NFE)
AF:
0.0119
AC:
13214
AN:
1111170
Other (OTH)
AF:
0.00783
AC:
472
AN:
60298
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
791
1583
2374
3166
3957
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
518
1036
1554
2072
2590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00592
AC:
902
AN:
152328
Hom.:
6
Cov.:
33
AF XY:
0.00542
AC XY:
404
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00185
AC:
77
AN:
41570
American (AMR)
AF:
0.00248
AC:
38
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00538
AC:
26
AN:
4834
European-Finnish (FIN)
AF:
0.00292
AC:
31
AN:
10618
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0106
AC:
721
AN:
68022
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
51
102
153
204
255
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00860
Hom.:
15
Bravo
AF:
0.00561
TwinsUK
AF:
0.0124
AC:
46
ALSPAC
AF:
0.0122
AC:
47
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.00919
AC:
79
ExAC
AF:
0.00728
AC:
883
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.0103
EpiControl
AF:
0.00937

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ARVCF: BS1, BS2 -

Jul 18, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 28, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.21
CADD
Pathogenic
30
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.017
T;.;T;.
Eigen
Uncertain
0.31
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Benign
0.52
D
LIST_S2
Uncertain
0.94
D;D;D;D
MetaRNN
Benign
0.012
T;T;T;T
MetaSVM
Benign
-0.40
T
MutationAssessor
Benign
1.4
L;.;.;.
PhyloP100
2.5
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-1.5
N;N;N;N
REVEL
Benign
0.28
Sift
Benign
0.19
T;T;T;T
Sift4G
Benign
0.30
T;T;T;T
Polyphen
0.99
D;.;.;.
Vest4
0.52
MVP
0.80
MPC
0.48
ClinPred
0.021
T
GERP RS
4.0
RBP_binding_hub_radar
0.97
RBP_regulation_power_radar
2.8
Varity_R
0.31
gMVP
0.60
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16982871; hg19: chr22-19965563; COSMIC: COSV99070614; COSMIC: COSV99070614; API